Leah Hermanson, NP
Nurse Practitioner · Sedalia, MONPI 1063959518
Payments from drug & device makers
Across 113 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$579
- Sanofi$381
- Boehringer Ingelheim$252
- GSK$152
- Grifols USA, LLC$124
- Dexcom, Inc.$99
- plus $679 from 19 others
What the payments were for
- Food & beverage$2,266100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 29 | $579 |
| Sanofi | 23 | $381 |
| Boehringer Ingelheim | 9 | $252 |
| GSK | 9 | $152 |
| Grifols USA, LLC | 6 | $124 |
| Dexcom, Inc. | 4 | $99 |
| Verona Pharma, Inc. | 4 | $75 |
| Viatris Specialty LLC | 3 | $74 |
| Johnson & Johnson | 1 | $69 |
| Jazz Pharmaceuticals Inc. | 3 | $69 |
| Pfizer | 4 | $55 |
| Insmed, Inc. | 2 | $45 |
| Amgen | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Genentech USA, Inc. | 2 | $30 |
| AbbVie | 1 | $23 |
| ZOLL Respicardia, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Philips North America LLC | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
How this compares
$2,266 in reported general payments places this provider in the 85th percentile of 1,898 nurse practitioner providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 174 | $150,119 |
| EliquisApixaban | 161 | $143,201 |
| JardianceEmpagliflozin | 88 | $89,988 |
| TrulicityDulaglutide | 55 | $58,012 |
| EntrestoSacubitril/Valsartan | 46 | $52,089 |
| OzempicSemaglutide | 41 | $42,047 |
| JanuviaSitagliptin Phosphate | 25 | $26,198 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $25,785 |
| MounjaroTirzepatide | 11 | $16,249 |
| Tresiba Flextouch U-100Insulin Degludec | 15 | $15,497 |
| RybelsusSemaglutide | 11 | $13,997 |
| Breo ElliptaFluticasone/Vilanterol | 30 | $13,898 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 65 | $8,788 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 19 | $7,473 |
| GemtesaVibegron | 12 | $5,694 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $69 | $150,119174 claims |
| PfizerEliquis | $55 | $143,201161 claims |
| Boehringer IngelheimJardiance | $252 | $89,98888 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $19 | $74,26166 claims |
| Novo NordiskOzempic, Rybelsus | $16 | $56,04452 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $152 | $39,68360 claims |
| AstraZenecaSymbicort | $579 | $5,22915 claims |
| Sanofi-aventis U.S. LLCLantus | $33 | $3,11534 claims |
| AbbVieSynthroid | $23 | $1,12313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,898 nurse practitioner providers in Missouri.
Other nurse practitioner in Sedalia
- Margaret YoungSedalia$11K
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
- Matthew BrunsBridgeton$126K
- Michelle DickensSpringfield$59K
- Robert HafnerKansas City$47K
- Tracey CarpenterChesterfield$47K
- Laura GrantSaint Charles$34K
- Courtney JefferyKansas City$24K
- Carrie Roth BettlachSaint Louis$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.